首頁 > 市場調查報告書 > 材料/化學品

包裝/容器

市場調查報告書

商品編碼

1773906

全球軟膠囊市場

Softgel Capsules

出版日期: 2025年07月22日 | 出版商:

Global Industry Analysts, Inc. | 英文 391 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球軟膠囊市場規模將達114億美國

全球軟膠囊市場規模預計在2024年為85億美元，到2030年將達到114億美元，2024年至2030年的複合年成長率為5.0%。明膠基/動物基軟膠囊是本報告分析的細分市場之一，預計其複合年成長率為4.1%，到分析期結束時規模將達到74億美元。非動物基軟膠囊市場在分析期間的複合年成長率預計為6.9%。

美國市場規模估計為 23 億美元，中國市場預計複合年成長率為 7.8%

美國軟膠囊市場規模預計2024年達到23億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到22億美元，在分析期間（2024-2030年）的複合年成長率為7.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為2.5%和5.0%。在歐洲，預計德國的複合年成長率為3.2%。

全球軟膠囊市場－主要趨勢與促進因素摘要

軟膠囊為何在市場上如此受歡迎？了解軟膠囊在藥品、保健品和化妝品中的作用

軟膠囊因其易於攝取、生物有效性提高和保存期限延長，已成為製藥、營養保健品和化妝品行業的首選劑型。與傳統的錠劑和硬膠囊不同，軟膠囊將液體或半固體製劑封裝在明膠基殼中，從而提高穩定性並促進更好吸收。它們廣泛用於遞送脂溶性維生素、 Omega-3脂肪酸、草藥萃取物、處方藥等。消費者對方便無味的口服劑型日益偏好的進一步推動了對軟膠囊的需求。此外，營養補充品消費量的不斷成長，尤其是注重健康的消費者尋求增強免疫力和抗衰老產品，也增強了市場。製藥業也正在利用軟膠囊技術來控制藥物釋放並提高患者的依從性，鞏固其作為現代醫學主要口服劑型的地位。

科技創新如何促進軟膠囊生產？探索封裝和配方科學的進步

軟膠囊產業在封裝技術和配方科學方面取得了重大進展，提高了產品品質和多功能性。植物親水膠體和鹿角菜膠菜膠等明膠替代品的創新促進了純素和素食選擇的開發，滿足了日益成長的飲食限制消費者群體的需求。此外，微膠囊技術的進步提高了活性成分的穩定性和生物有效性，使軟膠囊成為更有效的藥物傳遞形式。同樣，腸溶衣軟膠囊的推出實現了延遲釋放製劑，確保了最佳吸收並減少了胃刺激。自動化和連續生產流程進一步提高了生產效率，使製藥和營養保健品公司能夠降低成本並提高擴充性。隨著對軟膠囊配方不斷改進的研究，預計該行業將擴展到新的治療和功能性應用領域。

哪些挑戰影響軟膠囊市場？解決原料成本、法規合規性和貨架穩定性問題

儘管軟膠囊越來越受歡迎，但它們仍面臨著原料成本、嚴格監管要求和穩定性方面的挑戰。其使用動物性明膠引發了人們對供應鏈永續性和價格波動的擔憂。此外，不同地區的監管環境各不相同，要求製造商滿足嚴格的品管和標籤標準。穩定性問題，尤其是對濕敏性和熱敏性配方的穩定性問題，也為軟膠囊的生產和儲存帶來了挑戰。解決這些問題需要投資替代膠囊材料，跟上不斷發展的藥品法規，並改善增強穩定性的輔料，從而提高產品的耐久性。

軟膠囊市場成長的驅動力是什麼？識別關鍵產業成長趨勢和消費者偏好

軟膠囊市場的成長受到多種因素的推動，例如消費者對膳食補充劑需求的不斷成長、封裝技術的進步以及患者友好型劑型在藥品中的日益普及。健康生活方式的興起推動了軟膠囊維生素、礦物質和草藥補充劑的消費，尤其是在新興市場。此外，機能性食品和藥用化妝品的擴張為軟膠囊在美容和護膚產品中的應用帶來了新的機會。製藥業對止痛藥、心血管藥物和消炎藥等軟膠囊的偏好進一步增強了市場的成長。隨著膠囊設計和成分穩定性的不斷創新，軟膠囊市場預計將持續擴張，為消費者和醫療保健提供者提供可靠且高效的藥物輸送解決方案。

部分

類型（明膠基/動物基、非動物性）、用途（制酸劑/腸道調節劑、抗貧血劑、抗發炎劑、抗生素/抗菌劑、咳嗽/感冒藥、膳食補充劑、維生素/營養補充劑、懷孕）、最終用途（製藥公司、營養補充劑公司、化妝品公司、受託製造廠商）

受訪公司範例

Aenova Group GmbH
Algen Healthcare
Biborick Pharma
Biofield Pharma
Capsugel（Lonza）
CAPTEK Softgel International Inc.
Catalent, Inc.
Curivo Healthcare
Curtis Health Caps
Delpharm Evreux
Emcure Pharmaceuticals Limited
Estrellus
EuroCaps Ltd
Fuji Capsule Co., Ltd.
Greenwell Lifesciences
Guangdong Yichao Biological Co., Ltd.
Hunan ER-KANG Pharmaceutical Co Ltd
KD Pharma Group
Lifecare Neuro Products Ltd
Lifevision Healthcare
MEDGEL Private Limited
Olive Healthcare
Procaps Group
Saphnix Life Sciences
Sirio Pharma Company Ltd
Soft Gel Technologies, Inc.
Strides Pharma Science Limited
Swisschem Healthcare
Windzor Pharma Ltd
ZYUS Life Sciences Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Softgel Capsules estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.4 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Gelatin-based / Animal-based, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Non-Animal-based segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 7.8% CAGR

The Softgel Capsules market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Softgel Capsules Market - Key Trends & Drivers Summarized

Why Are Softgel Capsules Gaining Market Popularity? Understanding Their Role in Pharmaceuticals, Nutraceuticals, and Cosmetics

Softgel capsules have become a preferred dosage form in the pharmaceutical, nutraceutical, and cosmetic industries due to their ease of consumption, enhanced bioavailability, and extended shelf life. Unlike traditional tablets or hard capsules, softgel capsules encapsulate liquid or semi-solid formulations in a gelatin-based shell, offering improved stability and better absorption. They are widely used for delivering fat-soluble vitamins, omega-3 fatty acids, herbal extracts, and prescription medications. The growing consumer preference for convenient and tasteless oral dosage forms has further fueled the demand for softgel capsules. Additionally, the expansion of dietary supplement consumption, particularly among health-conscious consumers seeking immunity-boosting and anti-aging products, has strengthened the market. The pharmaceutical industry has also leveraged softgel technology for controlled drug release and improved patient compliance, reinforcing its position as a dominant oral dosage form in modern medicine.

How Are Technological Innovations Enhancing Softgel Capsule Manufacturing? Exploring Advancements in Encapsulation and Formulation Science

The softgel capsule industry has witnessed significant advancements in encapsulation techniques and formulation science, improving product quality and versatility. Innovations in gelatin alternatives, such as plant-based hydrocolloids and carrageenan, have led to the development of vegan and vegetarian softgel capsules, catering to a growing segment of consumers with dietary restrictions. Additionally, advances in microencapsulation technology have enhanced the stability and bioavailability of active ingredients, making softgel capsules more effective for targeted drug delivery. The introduction of enteric-coated softgels has also allowed for delayed release formulations, ensuring optimal absorption and reducing gastric irritation. Automation and continuous manufacturing processes have further streamlined production efficiency, reducing costs and improving scalability for pharmaceutical and nutraceutical companies. As research continues to refine softgel capsule formulations, the industry is expected to expand into new therapeutic and functional applications.

What Challenges Are Affecting the Softgel Capsules Market? Addressing Raw Material Costs, Regulatory Compliance, and Shelf Stability

Despite their growing popularity, softgel capsules face challenges related to raw material costs, strict regulatory requirements, and stability concerns. The use of gelatin, derived from animal sources, has raised concerns over supply chain sustainability and pricing fluctuations. Additionally, the regulatory landscape for softgel capsules varies across different regions, requiring manufacturers to meet stringent quality control and labeling standards. Stability issues, particularly for moisture-sensitive or heat-sensitive formulations, have also posed challenges in softgel manufacturing and storage. Addressing these concerns requires investments in alternative capsule materials, compliance with evolving pharmaceutical regulations, and advancements in stability-enhancing excipients to improve product durability.

What’s Driving the Growth of the Softgel Capsules Market? Identifying Key Industry Expansion Trends and Consumer Preferences

The growth in the softgel capsules market is driven by several factors, including increasing consumer demand for nutritional supplements, advancements in encapsulation technology, and rising adoption of patient-friendly dosage forms in pharmaceuticals. The surge in health-conscious lifestyles has encouraged the consumption of softgel-based vitamins, minerals, and herbal supplements, particularly in developed markets. Additionally, the expansion of functional foods and cosmeceuticals has introduced new opportunities for softgel delivery in beauty and skincare products. The pharmaceutical sector’s preference for softgels in pain relief, cardiovascular, and anti-inflammatory medications has further strengthened market growth. With continuous innovation in capsule design and ingredient stability, the softgel capsules market is expected to see sustained expansion, offering consumers and healthcare providers a reliable and efficient drug delivery solution.

SCOPE OF STUDY:

The report analyzes the Softgel Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Gelatin-based / Animal-based, Non-Animal-based); Application (Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement, Vitamin & Dietary Supplement, Pregnancy); End-Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

Aenova Group GmbH
Algen Healthcare
Biborick Pharma
Biofield Pharma
Capsugel (Lonza)
CAPTEK Softgel International Inc.
Catalent, Inc.
Curivo Healthcare
Curtis Health Caps
Delpharm Evreux
Emcure Pharmaceuticals Limited
Estrellus
EuroCaps Ltd
Fuji Capsule Co., Ltd.
Greenwell Lifesciences
Guangdong Yichao Biological Co., Ltd.
Hunan ER-KANG Pharmaceutical Co Ltd
KD Pharma Group
Lifecare Neuro Products Ltd
Lifevision Healthcare
MEDGEL Private Limited
Olive Healthcare
Procaps Group
Saphnix Life Sciences
Sirio Pharma Company Ltd
Soft Gel Technologies, Inc.
Strides Pharma Science Limited
Swisschem Healthcare
Windzor Pharma Ltd
ZYUS Life Sciences Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Softgel Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Demand for Easy-to-Swallow, Bioavailable Oral Dosage Forms Throws the Spotlight on Softgel Capsules
- Growth in Nutraceutical and OTC Supplement Market Spurs Consumption of Softgel-Based Delivery Systems
- OEM Innovation in Gelatin and Vegan Alternative Shells Expands Consumer Acceptance and Market Reach
- Expansion of Oil-Based APIs and Lipophilic Actives Supports Formulation in Softgel Format
- OEM Emphasis on Controlled Release, Enteric Coating, and Odor Masking Enhances Drug Stability
- Increasing Use in Omega-3, Vitamins, and Herbal Extract Supplements Supports Daily Health Product Demand
- OEM Development of Twin-Shell, Liquid-Fill, and Semi-Solid Formulations Drives Product Customization
- Rising Consumer Preference for Transparent Capsules and Clean Label Claims Supports Natural Formulation Trends
- OEM Integration of High-Speed Encapsulation, Leak-Proof Sealing, and Uniform Fill Weight Enhances Quality Control
- Growth in Contract Manufacturing Services Supports Small and Medium Brand Entry Into Competitive Markets
- OEM Focus on Advanced Printing and Brand Differentiation Technologies Enhances Market Visibility
- Expansion of Pediatric and Geriatric Therapeutics Supports Use in Non-Chewable, Taste-Masked Delivery
- OEM Partnerships With Nutraceutical and Functional Food Brands Accelerate Launch of New SKUs
- Rising Demand for Shelf-Stable, Moisture-Protected Supplements Strengthens Blister and Bottle Packaging Innovation
- OEM Strategies for Multi-Compartment Capsules and Dual Action Therapies Support Complex Formulations
- Surge in Personalized Supplementation Models Supports Small Batch, Custom Softgel Production
- OEM Investment in Kosher, Halal, and Non-GMO Certifications Enhances Global Export Potential
- Growth in Cold-Pressed Oils, CBD, and Botanical Oils Supports Use of Oil-Soluble Fill Formats
- OEM Emphasis on Global Regulatory Compliance, Gelatin Sourcing Transparency, and BSE-Free Supply Chains Strengthens Trust
- Focus on Digestive Comfort, Quick Absorption, and Dose Uniformity Enhances Softgel Preference Over Tablets
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Softgel Capsules Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Gelatin-based / Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Non-Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Pregnancy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Antacid & Anti-Flatulent Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Anti-Anemic Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Antibiotic & Antibacterial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Cough & Cold Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Health Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Vitamin & Dietary Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: World 15-Year Perspective for Nutraceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 42: World Historic Review for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: World 15-Year Perspective for Cosmeceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 44: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 45: World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 47: USA Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: USA 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 50: USA Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: USA Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: USA 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 53: USA Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: USA Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: USA 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
CANADA
- TABLE 56: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Canada 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 59: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Canada Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Canada 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 62: Canada Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Canada Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Canada 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
JAPAN
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 65: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Japan 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 68: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Japan Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Japan 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 71: Japan Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Japan Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Japan 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
CHINA
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 74: China Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: China 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 77: China Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: China Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: China 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 80: China Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: China Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: China 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
EUROPE
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 83: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 89: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 92: Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
FRANCE
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 95: France Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: France 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 98: France Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: France Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: France 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 101: France Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: France Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: France 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
GERMANY
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 104: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Germany 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 107: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Germany Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Germany 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 110: Germany Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Germany Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: Germany 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ITALY
- TABLE 113: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: Italy 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 116: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: Italy Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: Italy 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 119: Italy Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: Italy Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: Italy 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 122: UK Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: UK 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 125: UK Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: UK Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: UK 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 128: UK Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: UK Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: UK 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SPAIN
- TABLE 131: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Spain 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 134: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Spain Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Spain 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 137: Spain Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Spain Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: Spain 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 140: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: Russia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 143: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Russia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: Russia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 146: Russia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Russia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: Russia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Rest of Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Rest of Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Rest of Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Rest of Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 157: Rest of Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 166: Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 169: Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
AUSTRALIA
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 170: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 172: Australia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 173: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: Australia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 175: Australia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 176: Australia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: Australia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 178: Australia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
INDIA
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 179: India Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 181: India 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 182: India Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: India Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 184: India 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 185: India Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: India Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 187: India 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 188: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 190: South Korea 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 191: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: South Korea Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 193: South Korea 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 194: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: South Korea Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 196: South Korea 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Rest of Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Rest of Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
LATIN AMERICA
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 208: Latin America 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 211: Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 212: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 214: Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 215: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 217: Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 218: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 220: Argentina 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 221: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Argentina Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 223: Argentina 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 224: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Argentina Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 226: Argentina 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 227: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 229: Brazil 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 230: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Brazil Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 232: Brazil 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 233: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Brazil Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 235: Brazil 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
MEXICO
- TABLE 236: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 238: Mexico 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 239: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Mexico Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 241: Mexico 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 242: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Mexico Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 244: Mexico 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 249: Rest of Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 250: Rest of Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Rest of Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 253: Rest of Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
MIDDLE EAST
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 256: Middle East 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 259: Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 260: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 262: Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 263: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 265: Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
IRAN
- TABLE 266: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 268: Iran 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 269: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Iran Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 271: Iran 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 272: Iran Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Iran Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 274: Iran 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 275: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 277: Israel 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 278: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Israel Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 280: Israel 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 281: Israel Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Israel Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 283: Israel 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: Saudi Arabia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 289: Saudi Arabia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: Saudi Arabia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 292: Saudi Arabia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 293: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 295: UAE 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 296: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: UAE Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 298: UAE 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 299: UAE Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: UAE Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 301: UAE 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Rest of Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 307: Rest of Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Rest of Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 310: Rest of Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
AFRICA
- Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 311: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 313: Africa 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
- TABLE 314: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 315: Africa Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 316: Africa 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
- TABLE 317: Africa Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 318: Africa Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 319: Africa 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030